Azelaic acid and its salts
Canada Hotlist: Azelaic acid and its salts
Health Canada lists this ingredient as restricted; the listed conditions and warnings apply.
Décision réglementaire et conditions complètes
- Statut
- Restricted
- Rôle juridique
- Official guidance
- Résumé réglementaire
- Health Canada lists this ingredient as restricted; the listed conditions and warnings apply.
- Conditions et restrictions
Synonyms or related compounds: Nonanedioic acid; Disodium Azelate; Dipotassium Azelate · Maximum concentration: 14%
Identité de la substance
- Nom dans la source officielle
- Azelaic acid and its salts
- CAS
- 123-99-9; 52457-54-2; 132499-85-5; 17265-13-3; 27825-99-6
- EC
- Not supplied in this source row
- Correspondance d’identité
- Exact CAS: 123-99-9
- Ingrédient associé
- AZELAIC ACID
Données d’identité CosIng associées
Noms et alias
Description CosIng : Nonanedioic acid
Fonction cosmétique enregistrée : BUFFERING, FRAGRANCE
Pages de fonctions :BUFFERING, FRAGRANCE
Voir le profil complet de l’ingrédientAperçu multi-marchés pour cette identité
Fiches exactes associées actuellement présentes sur ce site. L’absence d’un marché signifie qu’aucune correspondance exacte n’a été importée, et non une autorisation d’utiliser la substance.
Canada
Fiche actuelle1 fiche associée · 1 avec conditions spécifiques
Ouvrir la fiche justificativeASEAN
1 fiche associée
Ouvrir la fiche justificativeSouth Korea
1 fiche associée · 1 avec conditions spécifiques
Ouvrir la fiche justificativeSaudi Arabia
1 fiche associée
Ouvrir la fiche justificative
Chimie vérifiée pour le CAS 123-99-9
Azelaic Acid
Nonanedioic acid is an alpha,-dicarboxylic acid that is heptane substituted at positions 1 and 7 by carboxy groups. It has a role as an antibacterial agent, an antineoplastic agent, a dermatologic drug and a plant metabolite. It is a dicarboxylic fatty acid and an alpha,omega-dicarboxylic acid. It is a conjugate acid of an azelaate and an azelaate(2-). — ChEBI
- Nom IUPAC
- nonanedioic acid
- Formule moléculaire
- C9H16O4
- Masse moléculaire
- 188.22 g/mol
- Masse exacte
- 188.10485899 Da
- Masse monoisotopique
- 188.10485899 Da
- XLogP3
- 1,6
- Surface polaire topologique
- 74,6 Ų
- Complexité moléculaire
- 147,0
- Charge formelle
- 0
- Donneurs de liaisons hydrogène
- 2
- Accepteurs de liaisons hydrogène
- 4
- Liaisons rotatives
- 8
- Atomes lourds
- 13
- Unités covalentes
- 1
Noms et synonymes signalés à PubChem
16 autres noms signalés
Identifiants de bases de données externes
- ChEBI:CHEBI:48131
- ChEMBL:CHEMBL1238
- EPA DTXSID:DTXSID8021640
- PubMed:22920095
- PubMed:22849351
- PubMed:22822212
- PubMed:22779176
- PubMed:22777226
- PubMed:22772611
- PubMed:22747347
- PubMed:22693913
- PubMed:22675394
- PubMed:22675387
- PubMed:22675033
- PubMed:22645576
Statistiques de structure avancées
- Stéréocentres atomiques définis
- 0
- Stéréocentres atomiques non définis
- 0
- Stéréocentres de liaison définis
- 0
- Stéréocentres de liaison non définis
- 0
- Caractéristiques pharmacophoriques 3D
- 6
- Cycles 3D
- 0
- Groupes hydrophobes 3D
- 0
- Caractéristiques d’accepteur 3D
- 4
- Caractéristiques de donneur 3D
- 0
- Centres anioniques 3D
- 2
- Centres cationiques 3D
- 0
- Conformères 3D
- 10
- Rotors 3D effectifs
- 8,0
Identifiants de structure lisibles par machine
- SMILES
C(CCCC(=O)O)CCCC(=O)O- InChI
InChI=1S/C9H16O4/c10-8(11)6-4-2-1-3-5-7-9(12)13/h1-7H2,(H,10,11)(H,12,13)- InChIKey
BDJRBEYXGGNYIS-UHFFFAOYSA-N
Preuves issues de bases de données scientifiques complémentaires
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Boiling Point: 286.5 °C at 1.00E+02 mm Hg Source: DrugBank
- Boiling Point: 357.1 °C; 287 °C at 100 mm Hg Source: Hazardous Substances Data Bank (HSDB)
- Boiling Point: BP: 365 °C (decomposes) Source: Hazardous Substances Data Bank (HSDB)
- Boiling Point: Distills above 360 °C with partial anhydride formation. BP: 286.5 °C at 100 mm Hg; 265 °C at 50 mm Hg; 237 °C at 15 mm Hg; 225 dg C at 10 mm Hg Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Monoclinic prismatic needles Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Yellowish to white crystalline powder Source: Hazardous Substances Data Bank (HSDB)
- Color/Form: Leaflets or needles Source: Hazardous Substances Data Bank (HSDB)
- Density: 1.225 g/cu cm at 25 °C Source: Hazardous Substances Data Bank (HSDB)
- pKa: 4.55 (at 25 °C) Source: DrugBank
- Dissociation Constants: pKa = 4.55 Source: Hazardous Substances Data Bank (HSDB)
- Flash Point: 210 °C (closed cup) Source: Hazardous Substances Data Bank (HSDB)
- LogP: 1.57 Source: DrugBank
- LogP: log Kow = 1.57 Source: Hazardous Substances Data Bank (HSDB)
- LogP: 1.57 Source: Human Metabolome Database (HMDB)
- Melting Point: 106.5 °C Source: DrugBank
- Melting Point: 160.5 °C Source: Hazardous Substances Data Bank (HSDB)
- Melting Point: 106.5 °C Source: Human Metabolome Database (HMDB)
- Physical Description: Dry Powder; Other Solid; Large Crystals Source: EPA Chemical Data Reporting (CDR)
- Physical Description: Yellowish to white solid; [HSDB] White flakes; [Acros Organics MSDS] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Physical Description: Solid Source: Human Metabolome Database (HMDB)
- Refractive Index: Index of refraction = 1.4303 at 111 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: 2400 mg/L (at 20 °C) Source: DrugBank
- Solubility: Slightly soluble in ethy ether, benzene, DMSO; soluble in ethanol Source: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in hot water, alcohol and organic solvents Source: Hazardous Substances Data Bank (HSDB)
- Solubility: One liter of water dissolves 1.0 g at 1.0 °C; 2.4 g at 20 °C; 8.2 g at 50 °C; 22 g at 50 °C ... 1000 g ether dissolves 18.8 g at 11 °C and 26.8 g at 15 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: In water, 2.40X10+3 mg/L at 20 °C Source: Hazardous Substances Data Bank (HSDB)
- Solubility: 2.4 mg/mL Source: Human Metabolome Database (HMDB)
- Vapor Pressure: 0.00000001 [mmHg] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Vapor Pressure: 1.07X10-8 mm Hg at 25 °C Source: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). Source: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Approximately 4% of the topically applied azelaic acid is systemically absorbed. Source: Toxin and Toxin Target Database (T3DB)
- Note: This chemical does not meet GHS hazard criteria for 6.5% (71 of 1087) of reports. Source: European Chemicals Agency (ECHA)
- Signal: Warning Source: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H315 (40.2%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (93.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] Source: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P264, P264+P265, P280, P302+P352, P305+P351+P338, P321, P332+P317, P337+P317, and P362+P364 (click each P-code to see the statement) Source: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 1087 reports by companies from 13 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Reported as not meeting GHS hazard criteria per 71 of 1087 reports by companies.; There are 11 notifications provided by 1016 of 1087 reports by companies with hazard statement code(s).; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. Source: European Chemicals Agency (ECHA)
- Cosmetic Ingredient Review Finding(s): Safe in the present practices of use and concentration. Ingredient, concentration, and use information are available in documents discoverable at https://cir-reports.cir-safety.org Source: Cosmetic Ingredient Review (CIR)
- Toxicity Summary: The exact mechanism of action of azelaic acid is not known. It is thought that azelaic acid manifests its antibacterial effects by inhibiting the synthesis of cellular protein in anaerobic and aerobic bacteria, especially Staphylococcus epidermidis and Propionibacterium acnes. In aerobic bacteria, azelaic acid reversibly inhibits several oxidoreductive enzymes including tyrosinase, mitochondrial enzymes of the respiratory chain, thioredoxin reductase, 5-alpha-reductase, and DNA polymerases. In anaerobic bacteria, azelaic acid impedes glycolysis. Along with these actions, azelaic acid also improves acne vulgaris by normalizing the keratin process and decreasing microcomedo formation. Azelaic acid may be effective against both inflamed and noninflamed lesions. Specifically, azelaic acid reduces the thickness of the stratum corneum, shrinks keratohyalin granules by reducing the amount and distribution of filaggrin (a component of keratohyalin) in epidermal layers, and lowers the number of keratohyalin granules. Source: Toxin and Toxin Target Database (T3DB)
- Environmental Bioconcentration: An estimated BCF of 3 was calculated in fish for 1,7-heptanecarboxylic acid(SRC), using a log Kow of 1.57(1) and a regression-derived equation(2). According to a classification scheme(3), this BCF suggests the potential for bioconcentration in aquatic organisms is low(SRC). Source: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: TERRESTRIAL FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to have moderate mobility in soil(SRC). The pKa of 1,7-heptanecarboxylic acid is 4.55(4), indicating that this compound will exist almost entirely in the anion form in the environment and anions generally do not adsorb more strongly to soils containing organic carbon and clay than their neutral counterparts(5). Volatilization from moist soil is not expected because the acid exists as an anion and anions do not volatilize. 1,7-Heptanecarboxylic acid is not expected to volatilize from dry soil surfaces(SRC) based upon a vapor pressure of 1.07X10-8 mm Hg(6). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(7). Source: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: AQUATIC FATE: Based on a classification scheme(1), an estimated Koc value of 170(SRC), determined from a log Kow of 1.57(2) and a regression-derived equation(3), indicates that 1,7-heptanecarboxylic acid is expected to adsorb to suspended solids and sediment(SRC). A pKa of 4.55(4) indicates 1,7-heptanecarboxylic acid will exist almost entirely in the anion form at pH values of 5 to 9 and therefore volatilization from water surfaces is not expected to be an important fate process(5). According to a classification scheme(6), an estimated BCF of 3(SRC), from its log Kow(2) and a regression-derived equation(7), suggests the potential for bioconcentration in aquatic organisms is low(SRC). Biodegradation data were not available(SRC, 2008) but straight chain carboxylic acids are expected to readily biodergade(8). Source: Hazardous Substances Data Bank (HSDB)
- Environmental Fate: ATMOSPHERIC FATE: According to a model of gas/particle partitioning of semivolatile organic compounds in the atmosphere(1), 1,7-heptanecarboxylic acid, which has a vapor pressure of 1.07X10-8 mm Hg at 25 °C(2), will exist in both the vapor and particulate phases in the ambient atmosphere. Vapor-phase 1,7-heptanecarboxylic acid is degraded in the atmosphere by reaction with photochemically-produced hydroxyl radicals(SRC); the half-life for this reaction in air is estimated to be 40 hrs(SRC), calculated from its rate constant of 9.8X10-12 cu cm/molecule-sec at 25 °C(SRC) that was derived using a structure estimation method(3). Particulate-phase 1,7-heptanecarboxylic acid may be removed from the air by wet or dry deposition(SRC). 1,7-Heptanecarboxylic acid does not contain chromophores that absorb at wavelengths >290 nm(4) and therefore is not expected to be susceptible to direct photolysis by sunlight(SRC). Source: Hazardous Substances Data Bank (HSDB)
- Consumer Uses: Not Known or Reasonably Ascertainable Source: EPA Chemical Data Reporting (CDR)
- Industry Uses: Monomers; Lubricating agent; Wetting agent (non-aqueous); Binder; Intermediate; Not Known or Reasonably Ascertainable; Corrosion inhibitor; Plasticizer Source: EPA Chemical Data Reporting (CDR)
- Cosmetic Ingredient Review Link: CIR ingredient: Azelaic Acid Source: Cosmetic Ingredient Review (CIR)
- Sources/Uses: Found in rancid oleic acid; [Merck Index] Used in organic syntheses, lacquers, alkyd resins, low-temperature plasticizers, adhesives, polyamides, urethane elastomers, and for the treatment of acne; [HSDB] Natural component of foods such as whole grain cereals and animal products; [REPROTOX] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Industrial Processes with risk of exposure: Painting (Pigments, Binders, and Biocides) [Category: Paint]; Working with Glues and Adhesives [Category: Other]; Plastic Composites Manufacturing [Category: Industry] Source: Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
- Uses: Azelaic acid is used in lacquers, alkyd resins, plasticizers, adhesives, polyamides, urethane elastomers, and organic syntheses. Azelaic acid is also used in treating of acne. Source: Hazardous Substances Data Bank (HSDB)
- Uses: Organic synthesis, lacquers, product of hydrotropic salts, alkyd resins, polyamides, polyester adhesives, low-temperature plasticizers, urethane elastomers Source: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >1000; Consumption (g per capita; approx.) in Germany (2009): 0.0122; Calculated removal (%): 92.2 Source: NORMAN Suspect List Exchange
- Uses: For the topical treatment of mild-to-moderate inflammatory acne vulgaris. Source: Toxin and Toxin Target Database (T3DB)
Mis en correspondance par: Existing checksum-valid CAS to unique PubChem CID match. Récupéré le: 2026-08-31. Ouvrir la fiche source
Les classifications scientifiques et les annotations de danger apportent du contexte et ne remplacent pas la décision réglementaire propre au marché indiquée ci-dessus.
Couverture des sources complémentaires et état des correspondances
| Source | Résultat | Vérifié |
|---|---|---|
| NIH PubChem PUG-View | Correspondance exacte | 2026-08-31 |
Une absence de correspondance enregistrée est une preuve utile que la source a été vérifiée ; ce n’est pas l’affirmation que la substance n’existe pas ailleurs.
Récupéré depuis NIH PubChem le 2026-08-31 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Chimie vérifiée pour le CAS 132499-85-5
Azelaic acid, disodium salt
- Nom IUPAC
- disodium;nonanedioate
- Formule moléculaire
- C9H14Na2O4
- Masse moléculaire
- 232.18 g/mol
- Masse exacte
- 232.06874749 Da
- Masse monoisotopique
- 232.06874749 Da
- Surface polaire topologique
- 80,3 Ų
- Complexité moléculaire
- 136,0
- Charge formelle
- 0
- Donneurs de liaisons hydrogène
- 0
- Accepteurs de liaisons hydrogène
- 4
- Liaisons rotatives
- 6
- Atomes lourds
- 15
- Unités covalentes
- 3
Noms et synonymes signalés à PubChem
3 autres noms signalés
Identifiants de bases de données externes
- EPA DTXSID:DTXSID40889659
Statistiques de structure avancées
- Stéréocentres atomiques définis
- 0
- Stéréocentres atomiques non définis
- 0
- Stéréocentres de liaison définis
- 0
- Stéréocentres de liaison non définis
- 0
- Conformères 3D
- 0
Identifiants de structure lisibles par machine
- SMILES
C(CCCC(=O)[O-])CCCC(=O)[O-].[Na+].[Na+]- InChI
InChI=1S/C9H16O4.2Na/c10-8(11)6-4-2-1-3-5-7-9(12)13;;/h1-7H2,(H,10,11)(H,12,13);;/q;2*+1/p-2- InChIKey
QFYNUCAKHMSPCY-UHFFFAOYSA-L
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.

Chimie vérifiée pour le CAS 52457-54-2
Azelaic acid, dipotassium salt
- Nom IUPAC
- dipotassium;nonanedioate
- Formule moléculaire
- C9H14K2O4
- Masse moléculaire
- 264.40 g/mol
- Masse exacte
- 264.01662189 Da
- Masse monoisotopique
- 264.01662189 Da
- Surface polaire topologique
- 80,3 Ų
- Complexité moléculaire
- 136,0
- Charge formelle
- 0
- Donneurs de liaisons hydrogène
- 0
- Accepteurs de liaisons hydrogène
- 4
- Liaisons rotatives
- 6
- Atomes lourds
- 15
- Unités covalentes
- 3
Noms et synonymes signalés à PubChem
5 autres noms signalés
Identifiants de bases de données externes
- EPA DTXSID:DTXSID501014948
Statistiques de structure avancées
- Stéréocentres atomiques définis
- 0
- Stéréocentres atomiques non définis
- 0
- Stéréocentres de liaison définis
- 0
- Stéréocentres de liaison non définis
- 0
- Conformères 3D
- 0
Identifiants de structure lisibles par machine
- SMILES
C(CCCC(=O)[O-])CCCC(=O)[O-].[K+].[K+]- InChI
InChI=1S/C9H16O4.2K/c10-8(11)6-4-2-1-3-5-7-9(12)13;;/h1-7H2,(H,10,11)(H,12,13);;/q;2*+1/p-2- InChIKey
RTMGQVSGXYZVTE-UHFFFAOYSA-L
Récupéré depuis NIH PubChem le 2026-09-02 par correspondance CAS à somme de contrôle valide. Les propriétés chimiques ne remplacent pas la décision réglementaire de cette page.
Source officielle et provenance
- Source enregistrée
- Health Canada Cosmetic Ingredient Hotlist
- Référence de la source
- Hotlist restricted entry 12
- Identifiant de la fiche source
restricted:12- Version de la source
- Health Canada Hotlist 2025-08-13
- Langue de la source
- English
- État de la traduction
- Original is English
- Source mise à jour le
- 2025-08-13
- Instantané vérifié le
- 2026-08-30 04:07 UTC
- Méthode de validation
- strict HTML tables t1=490 and t2=90
- SHA-256
8b52ff573d08373ee90121f6a701b3607e4a3d6fc748a7d56171eb53510af91a
Notes du jeu de données enregistré
- Couverture du jeu de données
- Administrative prohibitions, restrictions, conditions and warning requirements
- Note sur l’autorité
- Official Health Canada compliance indicator; not a complete safety clearance
Place de cette fiche dans le jeu de données du marché
Répartition des statuts
Un texte de conditions est présent pour 172 des 580 fiches actuelles. Un champ de conditions vide est interprété selon le type de fiche ci-dessus ; il n’est jamais converti en une affirmation d’utilisation sans restriction.
Canada contexte du marché
Complete Hotlist snapshot
Version de la couverture : Health Canada Cosmetic Ingredient Hotlist, 13 August 2025
All prohibited and restricted Hotlist entries, including conditions and warning requirements published in the official list.
Liste de contrôle de vérification
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
Sources officielles du marché
- Health Canada Cosmetic Ingredient HotlistOfficial Health Canada compliance indicator; not a complete safety clearance
Procédure de vérification et exhaustivité de la fiche
Avant d’utiliser ce résultat dans une décision de conformité
- Confirmez que « Azelaic acid and its salts » et chaque identifiant CAS/CE correspondent à la matière de votre spécification fournisseur.
- Search English/French names and CAS identifiers.
- Apply every restriction, concentration and label warning.
- Check Food and Drugs Act/Cosmetic Regulations requirements.
- Recheck the current Hotlist before notification or sale.
- Consignez la version de la source et revérifiez auprès de l’autorité de réglementation avant la fabrication, la notification ou la mise sur le marché.
Champs disponibles dans cette fiche
- Nom officiel de la substanceDisponible
- CASDisponible
- ECNon fourni
- Texte de condition distinctDisponible
- Date d’effetNon fourni
- Empreinte de l’instantané et méthodeDisponible
Questions auxquelles cette page répond
Citation stable
Azelaic acid and its salts. Hotlist restricted entry 12. Canada. Source version Health Canada Hotlist 2025-08-13. CosIng Checker regulatory record: https://cosingchecker.com/fr/regulations/ca/records/502/
Citez l’autorité de réglementation comme autorité juridique. Cette page est un index structuré de preuves et une aide à la vérification, et non un substitut au texte officiel ni à une évaluation juridique professionnelle.
Interprétation et limites pour Canada
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
Comment interpréter le rôle juridique
The authority uses this source as compliance guidance; the underlying legislation remains controlling.
Preuves sur cette page
- Résultat enregistré : Restricted
- Rôle juridique : Official guidance
- Version de la source : Health Canada Hotlist 2025-08-13
Ce que cela ne prouve pas
The Hotlist is an administrative compliance tool, not an exhaustive safety approval list.
Recherche complémentaire sur la substance auprès de sources faisant autorité
Aucune de ces sources ne prévaut sur la décision de marché ci-dessus.
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
Rechercher cette identité à la sourceFDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
Rechercher cette identité à la sourceILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
Rechercher cette identité à la sourceJapan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
Rechercher cette identité à la sourceNIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
Rechercher cette identité à la sourceOECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
Rechercher cette identité à la sourceUS EPA CompTox CTX APIs
Clé d’API requise pour l’importDTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
Rechercher cette identité à la source